Immuneering Corporation (IMRX) NASDAQ

1.56

+0.035(+2.30%)

Updated at March 13 03:56PM

Currency In USD

Valuation

Market Cap208.86M
Enterprise Value153.92M
P/E Ratio-0.8
PEG Ratio0.25
Price/Sales Ratio-0.51
Price/Book Ratio0.8
Enterprise/Revenue-0.08
Enterprise/EBITDA-0.12

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0.62
Operating Margin0.65

Management Effectiveness

Return On Assets-0.85
Return On Equity-0.79

Income Statement

Revenue0
Revenue/Share-3.16
Gross Profit-764,138
EBITDA-58.06M
Net Income-53.47M
Diluted EPS-1.88

Balance Sheet

Total Cash50.66M
Total Cash/Share1.7
Total Debt4.24M
Total Debt/Equity0.07
Current Ratio7.99
Book Value Per Share1.93

Price History

52-Week Change-73.55
52-Week High5.01
52-Week Low1
Moving Average 50 Days1.88
Moving Average 200 Days1.75

Statistics

Average Volume1.89M
Shares Outstanding31.05M
% Held by Institutions14.42

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A